Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant <i>Escherichia coli</i>

<div>Prostate/plasma ratios after administration of a single 3 g dose of oral fosfomycin.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

Figure 1: Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant <i>Escherichia coli</i> 